Dual energy CT is useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer

Sato,Kentaro; Morohashi,Hajime; Tsushima,Fumiyasu; Sakamoto,Yoshiyuki; Miura,Takuya; Fujita,Hiromasa; Umemura,Kotaro; Suzuki,Takahiro; Tsuruta,Satoru; Kura,Ryoto; Ono,Shuichi; Aoki,Masahiko; Hakamada,Kenichi

doi:10.3892/mco.2019.1834

Dual energy CT is useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer

Authors:
- Kentaro Sato
- Hajime Morohashi
- Fumiyasu Tsushima
- Yoshiyuki Sakamoto
- Takuya Miura
- Hiromasa Fujita
- Kotaro Umemura
- Takahiro Suzuki
- Satoru Tsuruta
- Ryoto Kura
- Shuichi Ono
- Masahiko Aoki
- Kenichi Hakamada
View Affiliations

Affiliations: Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036‑8562, Japan, Department of Radiation and Oncology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036‑8562, Japan
Published online on: March 28, 2019 https://doi.org/10.3892/mco.2019.1834
Pages: 625-630

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present retrospective study was to investigate the predictability of dual‑energy computed tomography (DECT) for pararectal lymph node (PRLN) metastasis and lateral pelvic lymph node (LPLN) metastasis in rectal cancer (RC). The present study involved 44 patients with RC who were examined by DECT and then underwent surgery between May 2015 and September 2017. LPLN dissection was performed in 24 patients. The normalized iodine concentration (nIC), the ratio of iodine concentration in the lymph node (LN) to that in the common iliac artery on DECT, of the largest PRLN and LPLN was calculated, and the association between LN metastasis and nIC was analyzed. The median nIC value for PRLNs was significantly lower in PRLN metastasis‑positive cases compared with PRLN metastasis‑negative cases in the arterial phase [0.18 vs. 0.25; P=0.01; cut‑off, 0.24; area under the curve (AUC), 0.733] and portal phase (0.47 vs. 0.61; P=0.03; cut‑off, 0.59; AUC, 0.701). A significant difference was not identified between the median maximum short axis diameter of PRLNs in PRLN metastasis‑positive and metastasis‑negative cases (7.6 vs. 6.4 mm; P=0.33). The nIC for LPLNs was not significantly different between LPLN metastasis‑positive and metastasis‑negative cases in the arterial phase (0.15 vs. 0.21; P=0.19); but was significantly lower in LPLN metastasis‑positive cases compared with LPLN metastasis‑negative cases in the portal phase (0.29 vs. 0.56; P=0.04; cut‑off, 0.29; AUC, 0.877). The maximum short axis diameter of LPLNs was significantly larger in metastasis‑positive cases compared with LPLN metastasis‑negative cases (9.1 vs. 4.8 mm; P=0.03; cut‑off, 7.0 mm; AUC, 0.912). In conclusion, the nIC was identified to be significantly lower in metastasis‑positive cases, which may be useful for the prediction of PRLN and LPLN metastases. A combination of size‑based diagnosis and DECT may increase the accuracy of preoperative diagnosis.

View Figures

View References

1	Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et al: Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 20:207–239. 2015. View Article : Google Scholar : PubMed/NCBI
2	MERCURY Study Group, ; Shihab OC, Taylor F, Bees N, Blake H, Jeyadevan N, Bleehen R, Blomqvist L, Creagh M, George C, et al: Relevance of magnetic resonance imaging detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg. 98:1798–1804. 2011. View Article : Google Scholar : PubMed/NCBI
3	Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A and Ollier JC: EORTC radiotherapy group trial 22921: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Medicine. 355:1114–1123. 2006. View Article : Google Scholar
4	Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem JG, et al: Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: A pilot trial. J Clin Oncol. 32:513–518. 2014. View Article : Google Scholar : PubMed/NCBI
5	Akiyoshi T, Matsueda K, Hiratsuka M, Unno T, Nagata J, Nagasaki T, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y and Ueno M: Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer. Ann Surg Oncol. 3 (Suppl 22):S614–S620. 2015. View Article : Google Scholar
6	Ogawa S, Hida JI, Ike H, Kinugasa T, Ota M, Shinto E, Itabashi M, Okamoto T, Yamamoto M, Sugihara K and Watanabe T: Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the lymph node committee of the japanese society for cancer of the colon and rectum. Int J Colorectal Dis. 32:1479–1487. 2017. View Article : Google Scholar : PubMed/NCBI
7	Liu H, Yan F, Pan Z, Lin X, Luo X, Shi C, Chen X, Wang B and Zhang H: Evaluation of dual energy spectral CT in differentiating metastatic from non-metastatic lymph nodes in rectal cancer: Initial experience. Eur J Radiol. 84:228–234. 2015. View Article : Google Scholar : PubMed/NCBI
8	Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, et al: Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): A multicenter, randomized controlled, noninferiority trial. Ann Surg. 266:201–207. 2017. View Article : Google Scholar : PubMed/NCBI
9	Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K and Sugihara K: Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum. 52:567–576. 2009. View Article : Google Scholar : PubMed/NCBI
10	Akasu T, Sugihara K and Moriya Y: Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol. 16:2779–2786. 2009. View Article : Google Scholar : PubMed/NCBI
11	Japanese Society for Cancer of the Colon Rectum, . Japanese Classification of Colorectal Carcinoma (8th). Kanehara Shuppan. Tokyo, Japan: 2013.
12	Aoki M, Takai Y, Narita Y, Hirose K, Sato M, Akimoto H, Kawaguchi H, Hatayama Y, Miura H and Ono S: Correlation between tumor size and blood volume in lung tumors: A prospective study on dual energy gemstone spectral CT imaging. J Radiat Res. 55:917–923. 2014. View Article : Google Scholar : PubMed/NCBI
13	Kanda Y: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplantat. 48:452–458. 2013. View Article : Google Scholar
14	Matsumoto K, Jinzaki M, Tanami Y, Ueno A, Yamada M and Kuribayashi S: Virtual monochromatic spectral imaging with fast kilovoltage switching: Improved image quality as compared with that obtained with conventional 120-kVp CT. Radiology. 259:257–262. 2011. View Article : Google Scholar : PubMed/NCBI
15	Zhang D, Li X and Litl B: Objective characterization of GE discovery CT750 HD scanner: Gemstone spectral imaging mode. Med Phys. 38:1178–1188. 2011. View Article : Google Scholar : PubMed/NCBI
16	Morohashi H, Sakamoto Y, Ichinohe D, Jin H, Miura T, Tsushima F, Ono S and Hakamada K: Evaluation of the therapeutic effect of using dual-energy CT for rectal cancer after neoadjuvant chemotherapy. Gan To Kagaku Ryoho. 43:1482–1484. 2016.(In Japanese). PubMed/NCBI
17	Kato T, Uehara K, Ishigaki S, Nihashi T, Arimoto A, Nakamura H, Kamiya T, Oshiro T, Ebata T and Nagino M: Clinical significance of dual-energy CT-derived iodine quantification in the diagnosis of metastatic LN in colorectal cancer. Eur J Surg Oncol. 41:1464–1470. 2015. View Article : Google Scholar : PubMed/NCBI
18	Naresh KN, Nerurkar AY and Borges AM: Angiogenesis is redundant for tumour growth in lymph node metastases. Histopathology. 38:466–470. 2001. View Article : Google Scholar : PubMed/NCBI
19	Kamiya T, Uehara K, Nakayama G, Ishigure K, Kobayashi S, Hiramatsu K, Nakayama H, Yamashita K, Sakamoto E, Tojima Y, et al: Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study. Eur J Surg Oncol. 42:829–835. 2016. View Article : Google Scholar : PubMed/NCBI
20	Hasegawa S, Goto S, Matsumoto T, Hida K, Kawada K, Matsusue R, Yamaguchi T, Nishitai R, Manaka D, Kato S, et al: A multicenter phase 2 study on the feasibility and efficacy of neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer. Ann Surg Oncol. 24:3587–3595. 2017. View Article : Google Scholar : PubMed/NCBI
21	Nakamura T, Yamashita K, Sato T, Ema A, Naito M and Watanabe M: Neoadjuvant chemoradiotherapy using S-1 and irinotecan in rectal cancer: Impact on long-term clinical outcomes and prognostic factors. Int J Radiat Oncol Biol Phys. 89:547–555. 2014. View Article : Google Scholar : PubMed/NCBI